Europe Garlic Extract Market Size, Share, Growth, and Country-level Forecast, 2026 to 2033

Europe Garlic Extract Market Size, Share, Growth, and Country-level Forecast, 2026 to 2033

Europe Garlic Extract Market by Form (Powdered, Oil-Based, Liquid), Application (Food and Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics and Personal Care, Animal Feed), Distribution Channel (B2B, B2C), and Country-level Analysis from 2026 - 2033

ID: PMRREP35005
Calendar

April 2026

192 Pages

Author : Abhijeet Surwase

Europe Garlic Extract Market Share and Trends Analysis

The Europe garlic extract market is estimated to grow from US$ 2.2 billion in 2026 to US$ 2.9 billion by 2033. The market is projected to record a CAGR of 4.2% during the forecast period from 2026 to 2033.

The market is growing steadily, driven by rising consumer awareness of natural wellness, preventive healthcare trends, and demand for functional ingredients. Germany, France, and the UK lead due to strong nutraceutical adoption and clean-label preferences, while Eastern Europe is the fastest-growing sub-region, supported by expanding health-conscious populations and rising interest in condition-specific, plant-based dietary supplements.

Key Industry Highlights:

  • Dominant Form Segment: Powder form held the largest share in 2025 with 40.1%, driven by its versatility in food fortification, ease of incorporation into capsules and tablets, cost-effectiveness, and strong demand from nutraceutical and functional food manufacturers across Europe.
  • Leading Country: Spain held a 38.7% share in 2025, supported by well-established nutraceutical industries, high consumer awareness of natural health ingredients, and strong regulatory frameworks that encourage clean-label and plant-based product formulations in countries such as Germany, France, and the UK.
  • Growth Indicators: Growth is driven by rising consumer inclination toward natural and herbal supplements, increasing demand for preventive healthcare solutions, growing popularity of functional foods and beverages, expanding applications in cardiovascular and immunity health, and strong preference for organic and sustainably sourced botanical ingredients.
  • Market Opportunities: Opportunities include organic and standardized garlic extract formulations, expansion into Eastern European markets, development of odorless and enteric-coated delivery formats, personalized nutrition solutions, and innovative applications targeting cardiovascular wellness, immune support, antimicrobial functionality, and age-related health conditions.

Market Dynamics

Driver: Rising Consumer Demand for Natural and Herbal Health Supplements

The Europe garlic extract market is strongly driven by the expanding consumer preference for natural and herbal health products. The European food supplements market was valued at USD 46 billion in 2024 and is projected to reach USD 93.2 billion by 2033, growing at an annual rate of 8.3%. A 2025 scientific review confirms that more Europeans are choosing natural products to support immunity, gut health, stress relief, and overall well-being, reflecting a lifestyle shift toward preventive wellness rather than reactive treatment. This growing inclination toward plant-based and herbal solutions has driven robust demand for botanical ingredients such as garlic extract, widely recognized for its cardiovascular and immune-supporting properties across the European nutraceutical landscape.

This demand is further reinforced by Europe's aging population and heightened health consciousness. According to Eurostat, approximately 21% of the EU's population was aged 65 or older in 2023, fuelling increased demand for bone, joint, and cognitive health products. According to the Robert Koch Institute, 58% of German adults use herbal supplements annually, primarily for sleep support, immune function, and digestive health. Eurostat statistics show that organic agriculture in the EU increased by more than 50% between 2012 and 2020, underscoring strong consumer demand for sustainably sourced, plant-derived ingredients. These trends collectively position garlic extract as a high-potential botanical ingredient across European nutraceutical and functional food formulations.

RESTRAINT: Odor and Taste Challenges Limiting Consumer Acceptance in Mainstream Formats

One of the most significant restraints for the European garlic extract market is the strong and persistent odor and taste associated with standard garlic formulations. Garlic consumption is a well-known cause of unpleasant breath and body odor, with volatile organosulfur compounds such as diallyl disulfide (DADS) and allyl methyl sulfide (AMS) responsible for the characteristic odor. These compounds persist for a long time after ingestion, creating a significant barrier to consumer adoption in mainstream supplement and functional food formats.

Although 64% of consumers use garlic for cardiovascular support, only 3% take it in supplement form, indicating significant untapped potential constrained in part by sensory aversion. The sensory challenge substantially limits garlic extract's commercial crossover into everyday nutrition categories.

The odor challenge is especially pronounced in Europe's mainstream food and beverage sector, where health-conscious consumers expect clean taste profiles. The unpleasant taste and odor of raw garlic make consumers reluctant to use it, and the major challenge in the production of processed garlic is to reduce the unpleasant taste and pungent odor. EU-wide surveys flag confusion about claims and risk information on botanical food supplement labels, which can depress uptake or shift consumer choices toward general "natural" cues rather than evidence-based use. This sensory and transparency gap makes odor-reduction technologies a critical commercial imperative for European garlic extract manufacturers seeking broader consumer reach across retail and functional food channels.

opportunity: Development of Odorless and Enteric-Coated Advanced Delivery Formats

The development of odorless and enteric-coated garlic extract formulations represents a substantial market opportunity in Europe, directly addressing the primary sensory barrier limiting broader consumer adoption. The most effective forms of garlic supplementation are aged garlic extract and enteric-coated tablets, as enteric-coated pills help improve absorption and reduce odor. Europe and North America show steady growth, fueled by innovations in delivery systems such as enteric-coated tablets and partnerships with health professionals.

Aged black garlic extract, commercially available in odorless capsule formats across European markets, has demonstrated cardiovascular efficacy in clinical settings, with one randomized study reporting a 20.8% reduction in the total cholesterol-to-HDL ratio after 12 weeks of supplementation with standardized odorless garlic extract.

Europe's cardiovascular disease burden further strengthens the commercial case for innovative garlic delivery formats. CVD causes 45% of all deaths in Europe, with nearly 49 million people living with the disease in the EU and an annual economic cost of €210 billion to EU economies. According to an OECD 2025 report, CVD remains the leading cause of death and disability in the EU, with cross-sectoral prevention policies and a growing emphasis on people-centered care serving as critical levers to reduce the burden of CVD across Europe. This policy environment creates a favorable landscape for nutraceutical solutions.

Manufacturers investing in advanced encapsulation, microencapsulation, and nano-emulsion technologies stand to capture significant market share among Europe's aging, health-conscious consumers seeking effective and odor-free cardiac wellness solutions.

Category-wise Analysis

By Form Insights - Powdered Dominates the Europe Garlic Extract Market

Powdered garlic extract dominates the European market with 40.1% share in 2025, primarily due to its exceptional versatility, cost-effectiveness, and seamless compatibility with industrial food manufacturing and nutraceutical processing. Garlic powder is a foundational ingredient across sauces, seasonings, meat products, soups, and ready meals. European buyers widely consider dried garlic predominantly in powder form, a core spice ingredient, and Chinese exports of dehydrated garlic reached 240,000 tonnes in 2024, growing 15% annually, with Europe as a principal destination market.

The 2024-2025 consumer research shows that 73% of European consumers actively seek products made with recognizable, simple ingredients, reinforcing demand for clean-label powder formats. Powder also offers superior shelf stability, precise dosing, and direct compatibility with capsule and tablet formulation, making it the preferred raw material form for both food processors and supplement manufacturers across Europe.

By Application Insights - Food and Beverages Dominates the European Garlic Extract Market

Food and beverages dominate the European garlic extract market by application, driven by the region's deeply rooted culinary traditions and growing industrial demand for natural, functional flavoring ingredients. European consumers are increasingly replacing salt, sugar, and synthetic additives with health-promoting flavor enhancers such as garlic, with market reports projecting 6-7% annual growth for dried garlic sales in Europe, supported by the EU's Spring 2025 GDP forecast and steady consumer demand.

France's food market alone is projected to reach €210.4 billion in 2024, growing 2.5% annually through 2029, while the French food additives market is expected to expand at 3.3% per year, illustrating the scale of opportunity for botanical ingredients. The World Health Organization's European Country-level office notes that non-communicable diseases account for around 80% of all deaths in the region, accelerating demand for garlic extract's dual role as both a functional health ingredient and a natural food flavoring across sauces, processed meats, soups, and fortified beverages.

Country-level Insights

Spain Garlic Extract Market Trends

The Spain garlic extract market is estimated to reach ≈US$ 0.8 Bn in 2026, Spain’s leadership is structurally driven by its agricultural scale, processing base, and consumption intensity. According to the European Commission, Spain is the largest garlic producer in Europe, contributing over 273,000 tonnes annually, far ahead of other countries. More recent data shows production around 240,000-246,000 tonnes in 2024, with historical peaks of 316,000 tonnes. Spain also exports over 120,000 tonnes, accounting for roughly two-thirds of Europe’s garlic exports, indicating strong upstream control of raw material supply.

Additionally, domestic consumption is exceptionally high at ~2.4 kg per capita, among the highest in Europe, supporting a large processing industry for garlic-based products, such as extracts. This combination of dominant production, export infrastructure, and high consumption creates a vertically integrated ecosystem, enabling Spain to lead the garlic extract market.

UK Garlic Extract Market Trends

The UK’s growth is primarily demand-driven, supported by import dependence and structural supply gaps. The country has minimal domestic garlic production, making it highly reliant on imports for both fresh garlic and processed derivatives, such as extracts. Import data shows that the UK handled ~35,000 tonnes of garlic in 2024, with 50% supplied by developing countries, reflecting diversification and expanding sourcing networks. A key trend is the sharp decline in intra-European supply (from 33,400 to 17,500 tonnes between 2020 and 2024), pushing UK buyers toward alternative global suppliers, especially China and Argentina. This shift indicates increasing reliance on processed and shelf-stable formats such as garlic extracts.

Additionally, changing consumption patterns, driven by convenience foods and ethnic cuisines, are accelerating demand. With limited domestic cultivation and evolving supply chains post-Brexit, the UK market is structurally positioned for faster growth in garlic extract consumption compared to production-heavy countries such as Spain.

Competitive Landscape

Europe garlic extract market is moderately competitive, with key players focusing on product quality, standardization, and supply chain efficiency. Companies emphasize organic sourcing, advanced extraction technologies, and clean-label formulations. Strategic partnerships, export expansion, and growing applications in food, nutraceuticals, and pharmaceuticals are driving competition and market positioning across the region.

Key Industry Developments:

  • In April 2026, the European garlic contact group called for stricter controls on garlic imports to protect domestic producers and ensure fair market conditions. The group raised concerns over rising low-cost imports, particularly from non-EU countries, which were impacting local farmers’ competitiveness. It emphasized the need for tighter quality checks, improved traceability, and enforcement of existing trade regulations.
  • In January 2025, Bayer and Ecospray entered into a distribution agreement for a new biological crop protection product sourced from garlic. The partnership aimed to expand access to sustainable agricultural solutions by leveraging Bayer’s global distribution network and Ecospray’s expertise in plant-based formulations.

Companies Covered in Europe Garlic Extract Market

  • Sabinsa
  • Mane KANCOR
  • Naturalin Bio-Resources Co., Ltd
  • Pharmalink Extracts Europe
  • Silverline Chemicals
  • Agroproducts Manufacturers
  • Yuantai Organic
  • ICHIMARU PHARCOS Co., Ltd.
  • The Garden of Naturalsolution
  • Others
Frequently Asked Questions

Europe garlic extract market is projected to be valued at US$ 2.2 Bn in 2026.

Rising health awareness, antimicrobial benefits, food processing demand, nutraceutical growth, and expanding natural ingredient adoption.

The Europe garlic extract market is poised to witness a CAGR of 4.2% between 2026 and 2033.

Expansion in nutraceuticals, functional foods, pharmaceuticals, clean-label products, exports, and advanced extraction technologies.

Sabinsa, Mane KANCOR, Naturalin Bio-Resources Co., Ltd, Pharmalink Extracts Europe, Silverline Chemicals, Agroproducts Manufacturers.

UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -